Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- (Q)SAR
- Adequacy of study:
- key study
- Study period:
- 2019
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- results derived from a valid (Q)SAR model and falling into its applicability domain, with adequate and reliable documentation / justification
- Justification for type of information:
- Acute dermal toxicity refers to those adverse effects occurring following a single dermal (skin) exposure to the substance within 24 h.
The aim was to estimate the acute toxicity by dermal route of target substance.
stimation of the biological activity (acute toxicity by dermal route)
The computational simulation was performed based on the read-across approach.The readacross is one of the so-called alternative test methods recommended by REACH, where the predictions are based on the experimental data available for the most similar compounds. The predictions were performed according to the Read-Across Assessment Framework (RAAF), which assumes six different risk assessment scenarios of chemical compounds.
Applied tool:
The OECD QSAR Toolbox, version 4.3
Procedure of analysis:
I. Profiling of the target substance in order to retrieve relevant information related to
mechanism of action and observed or simulated metabolites
II. Category (source compounds) search based on selected criteria:
a. analogues are aliphatic amines according to US-EPA New Chemical Categories
b. analogues are structurally similar to the target compound (similarity >20%)
c. analogues have the same alert “High level” according to the Cramer profile.
III. Data collection for the analogues (OECD Toolbox database/ECHA CHEM).
IV. Toxicity prediction for the target substance
V. Category consistency check in order to assess the quality of the prediction
Applied scenario:
Scenario 2
Toxicity prediction for the target substance:
This read-across is based on the fact that the organism is not exposed to common compounds but rather, as a result of similarity, to chemicals which have similar (eco)toxicological and fate properties.
The target substance is an organometallic compound containing manganese (Mn) centres, glycine (Gly) ligands. The metallic centres of the substance are linked by oxygen coordination bonds of the Gly ligands.
The target and source chemicals are classified as “Aliphatic amines” according to US-EPA New Chemical Categories and have the same “High level” alert responsible for the toxic effect based on the Cramer profiler. Moreover, analogue is structurally similar to the target compound in more than 20%. The sodium (2-aminoethyl)amino]ethanesulphonate was taken into account for the prediction.
The acute dermal toxicity for the source compound was performed according to:
Test guideline: OECD 402
Endpoint: LD50
Test organism: rat
The read-across prediction of the acute dermal toxicity for the target substance was performed based on the approach “one to one”.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 019
- Report date:
- 2019
Materials and methods
- Principles of method if other than guideline:
- In order to meet regulatory needs, reliability of the predicted results should be assessed. In case of classic quantitative structure-activity relationships (QSAR) modelling, this idea can be realised by analysing, whether the predicted value is located within so-called applicability domain. The applicability domain is a theoretical region, defined by the range of toxicity values and structural descriptors for the training compounds, where the predictions may be considered as realistic ones. In a specific case of read-across, the assessment is performed based on the assessment of degree of similarity between the source and target compounds (in %). Moreover, the internal consistency of the group of source compounds (called „category” in OECD QSAR Toolbox nomenclature, independently which approach: analogue approach or category approach is used). The category consistency check could be based on the parameters describingthe structural similarity and/or properties as well as mechanistic similarity of the tested
compounds. For example, all members of the category (analogues as well as target substance) need to have the same functional groups and endpoint specific alerts.
In the case of read-across-based prediction of the acute dermal toxicity of the dehydrate manganese (II) glycine sulphate (VI), the read-across hypothesis considers that source and target compounds have the same structural features related to “Aliphatic amines” (US EPA New Chemical Categories) and have the same “High level” alert responsible for the toxic effect based on the Cramer profiler. Based on the Dice measure, the structural similarity between analogues and the target compound was higher than 20%. The sodium 2-[(2-aminoethyl)amino]ethanesulphonate was taken into account for the prediction.
Besides, the category consistency, the boundaries of the applicability domain are verified by the critical value of log KOW. In case of “one to one” approach, this criterium would be met only if source and target compounds are the same substance. Thus, information that “target chemical is out of domain” considering this criterium is not critical in this situation.
The structural similarity between the source (sodium 2-[(2-aminoethyl)amino]ethanesulphonate) and the target compound (Mn(Gly)SO4) equals to 27.3%. - GLP compliance:
- no
- Remarks:
- QSAR
Test material
- Reference substance name:
- catena-((μ4-sulfato)-(μ2-glycinato)-manganese
- Cas Number:
- 2087529-10-8
- Molecular formula:
- Mn(SO4)(C2H5NO2)
- IUPAC Name:
- catena-((μ4-sulfato)-(μ2-glycinato)-manganese
- Test material form:
- solid
Constituent 1
Results and discussion
Effect levels
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
Applicant's summary and conclusion
- Interpretation of results:
- Category 5 based on GHS criteria
- Conclusions:
- The acute dermal toxicity for the target substance is predicted at level LD50 >= 2000 mg/kg
- Executive summary:
The source and target compounds have the same structural features related to “Aliphatic amines” (US EPA New Chemical Categories) and have the same “High level” alert responsible for the toxic effect based on the Cramer profiler. The analogues search was performed assuming at least 20% structural similarity between the source and target substances. The toxicity prediction was performed based on the experimental data included in the OECD QSAR Toolbox. The sodium 2-[(2-aminoethyl)amino]ethanesulphonate would have similar structural features (organic functional groups) and cause similar toxic effect (Cramer profile) as well as the experimental data related to its acute dermal toxicity was available. Therefore, the prediction is based only on the sodium 2-[(2-aminoethyl)amino]ethanesulphonate.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.